MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer

Peking University

Status: Unknown

Conditions: Multi-disciplinary Treatment

Treatments: Procedure: Multi-disciplinary Treatment

Study type: Observational

Funder types: Other

Identifiers

NCT03400657

CSMDT-01

Details and patient eligibility

About

This is a prospective, multicenter, non-interventional, controlled clinical study. Evaluate MDT performance and benefit analysis in patients with advanced gastric or colorectal cancer after MDT discussion under real medical practice.

Enrollment: 484 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Histopathological diagnosis of recurrent / metastatic gastric or colorectal cancer.
2. Participate in formal MDT discussions at the Research Center.
3. MDT decision-making at least two subjects involved in treatment.
4. Patient informed consent and signed written consent.

Exclusion criteria

1. Early or locally advanced gastric cancer or colorectal cancer.
2. Accept informal MDT discussions.
3. MDT decisions recommend only a single subject for treatment of patients.
4. MDT decisions recommend only palliative patients.

Trial design

484 participants in 3 patient groups

fully implemented to the MDT decision

Description:

group of patients fully implemented to the MDT decision

Treatment:

Procedure: Multi-disciplinary Treatment

not completly implemented to the MDT-decision

Description:

group of patients not completly implemented to the MDT decision

Treatment:

Procedure: Multi-disciplinary Treatment

not implemented to the MDT decision

Description:

group of patients not implemented to the MDT decision

Treatment:

Procedure: Multi-disciplinary Treatment